![Joanna Lis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joanna Lis
Directeur/Bestuurslid bij International Society for Pharmacoeconomics & Outcomes Rsch
Profiel
Joanna Lis is currently working as a Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate and doctorate degree from Uniwersytet Jagiellonski and an MBA from Kozminski University.
Actieve functies van Joanna Lis
Bedrijven | Functie | Begin |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Directeur/Bestuurslid | - |
Opleiding van Joanna Lis
Uniwersytet Jagiellonski | Doctorate Degree |
Kozminski University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |